The results suggest that Tirofiban is a safe and tolerable therapy drug for ACS(UA/NSTEMI) patients referred to percutaneous coronary intervention,the same as to high risk stratificated patients.

• 国产替罗非班治疗对经皮血管成形术后急性冠脉综合征(UA/NSTEMI)患者是安全有效的,对高危险分层患者亦可安全使用。